Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease.
Level 4 - case-series / case-control
Diagnostic case-control study with healthy controls and selective reference standard verification
PubMed 8075779 · doi:10.1530/eje.0.1310113
What was done
Researchers evaluated high-frequency pretibial ultrasound (using 10- and 13-MHz probes) for diagnosing pretibial myxedema (PTM). The study included 76 patients with thyroid disease (58 with Graves' disease, 13 with Hashimoto's thyroiditis, and 5 with idiopathic hypothyroidism; 64 had associated ophthalmopathy) and 32 healthy control subjects. Ultrasound measured the thickness of dermis plus subcutaneous tissue (D1) and deep dermis alone (D2). Punch biopsies were performed in 11 patients for light microscopy confirmation.
What was found
Clinical examination identified suspected PTM in 21 of 76 patients (28%). Ultrasound showed increased skin thickness in 25 patients (33%), with mean D1 and D2 values significantly higher than controls (p < 0.00001). Ultrasound was positive in 16 of 21 patients (76%) with clinically suspected PTM and in 20 of 64 patients (31%) with ophthalmopathy. Histopathology confirmed PTM in all 11 biopsied patients. Exact thickness measurements, confidence intervals, and sensitivity/specificity values were not reported in the abstract.
Why it matters
High-frequency ultrasound provides a non-invasive, objective tool to detect pretibial tissue involvement in autoimmune thyroid disease, potentially identifying subclinical lesions that are not apparent on routine physical examination.
Limits
The abstract omits numeric skin thickness values, variances, and formal test accuracy metrics. Histological verification was limited to a convenience subset of 11 patients, creating verification bias. Comparing thyroid patients against healthy controls rather than patients with differential lower-extremity skin conditions limits clinical diagnostic utility.
Cited by
- supports Hypothyroidism causes myxedema, a proteinaceous edema visible in tissues under ultrasound.